Stock listing
Ndatalyze Corp
Selected listing: NDAT · NEO · CAD · CA
Ndatalyze Corp (Cboe Canada: NDAT), Health Technology. Latest release Oct 5, 2026: nDatalyze Corp. RTO-related Special Meeting Voting Results.
- Ticker
- Cboe Canada: NDAT
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- Cboe Canada
- Currency
- CAD
About Ndatalyze Corp
The company focuses on providing innovative solutions in its sector, aiming to enhance operational efficiency and drive growth. Investors can find more information about Ndatalyze Corp's performance and strategic initiatives on its public company page.
Latest news from Ndatalyze Corp
nDatalyze Corp. RTO-related Special Meeting Voting Results
October 5, 2026
NDatalyze Corp. Enters A Binding Business Combination Agreement With Prism Diversified Ltd.
May 15, 2026
NDatalyze Corp. Announces Appointment of Commercial Sales Director for the Epitome Hockey Platform.
April 27, 2026
NDatalyze Corp. Announces Adoption of Semi-Annual Financial Reporting Trial, provides a progress report on the potential RTO, and updates the Epitome sports performance assessment project
March 26, 2026
NDatalyze Corp. Updates The Proposed RTO With An Alberta-Based Mining Company
March 11, 2026